FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall

The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.

from Health and Science https://ift.tt/OMIgPfT
https://ift.tt/PNcsCwX
https://ift.tt/ioTVrtQ